Key Market Segments:
By Technique
-
Genomics
-
Proteomics
-
Epigenetics
-
Metabolomics
By Technology
-
Sequencing Techniques
-
NGS
-
Sanger Sequencing
-
Pyro Sequencing
-
-
qPCR
-
Immunohistochemistry
-
In Situ Hybridization
-
Microarray
By Application
-
Personalized Cancer Medicine
-
Oncological Diagnostics
-
Research
-
Cancer Research
-
Biomarker Discovery
-
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
-
US
-
Canada
-
Mexico
Europe
-
Eastern Europe
-
Poland
-
Romania
-
Hungary
-
Turkey
-
Rest of Eastern Europe
-
-
Western Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Netherlands
-
Switzerland
-
Austria
-
Rest of Western Europe
-
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Vietnam
-
Singapore
-
Australia
-
Rest of Asia Pacific
Middle East & Africa
-
Middle East
-
UAE
-
Egypt
-
Saudi Arabia
-
Qatar
-
Rest of Middle East
-
-
Africa
-
Nigeria
-
South Africa
-
Rest of Africa
-
Latin America
-
Brazil
-
Argentina
-
Colombia
-
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Ans: North America dominated the Tumor Profiling Market in 2024, holding around 45% share, driven by advanced infrastructure, high adoption of precision medicine, and strong R&D investment.
Ans: In 2024, the personalized cancer medicine application segment led with 41% revenue share, reflecting growing adoption of precision oncology and tailored treatment strategies worldwide.
Ans: Key growth is driven by technological advancements such as next-generation sequencing, liquid biopsies, and AI-integrated bioinformatics improving accuracy, personalization, and treatment recommendations in oncology diagnostics.
Ans: The Tumor Profiling Market was valued at USD 11.55 billion in 2024, supported by rising cancer prevalence and expanding applications of genomic and molecular diagnostics.
Ans: The Tumor Profiling Market is expected to grow at a CAGR of 10.04% from 2025 to 2032, fueled by precision oncology, NGS, and liquid biopsy innovations.